UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck

Not Applicable

Recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS)

First Posted Date: 2021-03-18

Last Posted Date: 2023-07-13

Lead Sponsor: University of Rochester

Target Recruit Count: 75

Registration Number: NCT04805528

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

The Effects of a 12 Week Home-based Exercise Intervention on Physical Performance in Patients With Cancers of the Gastrointestinal Tract With Pre- Cachexia or Cachexia

Not Applicable

Completed

Conditions: Cachexia
Weight Loss
Gastrointestinal Cancer

Interventions: Other: EXCAP©®

First Posted Date: 2021-03-17

Last Posted Date: 2021-03-17

Lead Sponsor: University of Rochester

Target Recruit Count: 25

Registration Number: NCT04802486

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Visual Rehabilitation After Occipital Stroke

Not Applicable

Recruiting

Conditions: Vision Loss Partial
Quadrantanopia
Visual Field Defect, Peripheral
Peripheral Visual Field Defect
Hemianopsia
Hemianopia
Visual Fields Hemianopsia
Homonymous Hemianopsia
Occipital Lobe Infarct
Stroke, Ischemic

Interventions: Device: Subacute Training in the blind field
Device: Subacute Training in the intact field
Device: Chronic Training in the blind field

First Posted Date: 2021-03-15

Last Posted Date: 2024-11-13

Lead Sponsor: University of Rochester

Target Recruit Count: 60

Registration Number: NCT04798924

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

Phase 4

Completed

Conditions: Atrial Fibrillation

Interventions: Drug: Placebo
Drug: dapagliflozin

First Posted Date: 2021-03-10

Last Posted Date: 2024-12-04

Lead Sponsor: University of Rochester

Target Recruit Count: 25

Registration Number: NCT04792190

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Not Applicable

Active, not recruiting

Conditions: Myelodysplastic Syndromes
Acute Myeloid Leukemia

Interventions: Behavioral: Telehealth

First Posted Date: 2021-02-09

Last Posted Date: 2023-04-26

Lead Sponsor: University of Rochester

Target Recruit Count: 20

Registration Number: NCT04745676

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer
Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Smoldering Multiple Myeloma (SMM)

Interventions: Drug: Curcumin plus Piperine

First Posted Date: 2021-02-01

Last Posted Date: 2024-07-12

Lead Sponsor: University of Rochester

Target Recruit Count: 40

Registration Number: NCT04731844

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Phase 4

Withdrawn

Conditions: Retinopathy, Diabetic

Interventions: Drug: Aflibercept Injection
Drug: Sham injection

First Posted Date: 2021-01-08

Last Posted Date: 2021-05-05

Lead Sponsor: University of Rochester

Registration Number: NCT04702048

Locations: 🇺🇸
Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York, United States

Wireless TENS for Peripheral Edema (Lower Limb Swelling)

Phase 1

Active, not recruiting

Conditions: Peripheral Edema

Interventions: Device: Transcutaneous Electrical Nerve Stimulation (TENS)

First Posted Date: 2020-12-23

Last Posted Date: 2023-08-09

Lead Sponsor: University of Rochester

Target Recruit Count: 52

Registration Number: NCT04680533

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Network Intervention to Prevent Vaping

Not Applicable

Conditions: Social Networking
Vaping
Preventive Psychiatry

Interventions: Behavioral: Above the Influence-Vaping (ATI-V)

First Posted Date: 2020-12-21

Last Posted Date: 2024-08-06

Lead Sponsor: University of Rochester

Target Recruit Count: 3840

Registration Number: NCT04678245

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

Not Applicable

Completed

Conditions: Cognitive Impairment
Cancer-related Problem/Condition

Interventions: Behavioral: MAAT-G
Behavioral: Supportive therapy (time and attention control)

First Posted Date: 2020-12-16

Last Posted Date: 2024-05-06

Lead Sponsor: University of Rochester

Target Recruit Count: 85

Registration Number: NCT04669301

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy